Increasing Prevalence of Oral Diseases to Augment the Dental Membranes and Bone Graft Substitutes Market Growth

 

Dental Membranes and Bone Graft Substitutes are used in bone graft surgeries. Dental bone grafting is a medical procedure that replaces missing tooth lost due to a dental disease, an accident, or old age. Dental membrane and bone graft substitutes are extensively used in implant procedures that require additional bone support.

Market Dynamics:

Increasing prevalence of dental/oral diseases, such as oral cancer, cavities (tooth decay), and gum disease, is expected to propel the growth of the Dental Membranes and Bone Graft Substitutes Market. For instance, oral disease affects 3.9 billion people worldwide, according to FDI World Dental Federation. Moreover, according to the Centers for Disease Control and Prevention (CDC), more than 1 in 4 (26%) adults in the United States have untreated tooth decay and around half (46%) of all adults aged 30 years or older show signs of gum disease.

Moreover, the increasing patient population coupled with the growing geriatric population is expected to augment the growth of the dental membranes and bone graft substitutes market. For instance, according to the World Health Organization (WHO), by 2050, the world's population aged 60 years and older is expected to total 2 billion, up from 900 million in 2015.

Increasing demand for bone graft substitutes is also expected to fuel the growth of the dental membranes and bone graft substitutes market. For instance, in 2019, Zimmer Biomet launched OsseoGuard non-resorbable dental membranes and sutures to expand its product portfolio.

However, high cost of bone graft procedures and stringent government regulations are expected to restrain the dental membranes and bone graft substitutes market growth.

Competitive Analysis:

Major players operating in the dental membrane and bone graft substitute market are Citagenix, Inc., Dentsply Sirona Inc., Institut Straumann AG, RTI Surgical Holdings, Inc., LifeNet Health, BioHorizons, Inc., ACE Surgical Supply Company, Inc., Geistlich Pharma North America Inc., and Zimmer Biomet Holdings, Inc.

Major players in the market are adopting various strategies, such as partnership, collaboration, merger and acquisition, etc., to strengthen their market presence. For instance, in September 2019, Straumann and Modern Dental Group Limited teamed up to create Peak Dental Solutions Hong Kong Ltd., a distribution company that will serve the dental communities in Hong Kong and Macau.

Moreover, in March 2018, Dentsply announced the signing of a definitive agreement to acquire OraMetrix, a leading industry provider of innovative 3-D technology solutions improving the quality and efficiency of orthodontic care.